These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9717503)

  • 41. Experimental AIDS drug, d4T, now available to patients in critical need.
    Ann Allergy; 1993 Apr; 70(4):A19. PubMed ID: 8385427
    [No Abstract]   [Full Text] [Related]  

  • 42. Antiviral drugs in the treatment of AIDS: what is in the pipeline ?
    Stellbrink HJ
    Eur J Med Res; 2007 Oct; 12(9):483-95. PubMed ID: 17933730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Resistance tests to improve therapy. More specific use of AIDS drugs].
    Paukstadt W
    MMW Fortschr Med; 1999 Sep; 141(37):18. PubMed ID: 10897968
    [No Abstract]   [Full Text] [Related]  

  • 44. [Current AIDS drugs].
    Praxis (Bern 1994); 1997 Feb; 86(9):364-5. PubMed ID: 9157508
    [No Abstract]   [Full Text] [Related]  

  • 45. [Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008].
    Zheng PR; Xue H; Xiao ZY; Liu G
    Yao Xue Xue Bao; 2010 Feb; 45(2):154-64. PubMed ID: 21351426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental AIDS drug, d4T, now available to patients in critical need.
    Ann Allergy; 1993 Nov; 71(5):A-27. PubMed ID: 8250344
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacoresistance: an emerging clinical problem.
    Carosi G
    J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):9-14. PubMed ID: 9689572
    [No Abstract]   [Full Text] [Related]  

  • 48. FDA approves AIDS drug.
    Am Pharm; 1992 Sep; NS32(9):13-4. PubMed ID: 1332462
    [No Abstract]   [Full Text] [Related]  

  • 49. The patient's choice.
    Crigger BJ
    Hastings Cent Rep; 1991; 21(6):4. PubMed ID: 1765465
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug targets cellular enzyme.
    AIDS Patient Care STDS; 1999 Apr; 13(4):247-8. PubMed ID: 10351898
    [No Abstract]   [Full Text] [Related]  

  • 51. Panel backs AIDS drugs.
    AIDS Read; 2007 Nov; 17(11):528. PubMed ID: 18069147
    [No Abstract]   [Full Text] [Related]  

  • 52. DdI approval offers second chance.
    Albert SG
    Am Pharm; 1991 Dec; NS31(12):6. PubMed ID: 1763779
    [No Abstract]   [Full Text] [Related]  

  • 53. AIDS researchers seek criteria for vaccines.
    Check E
    Nature; 2003 May; 423(6936):107. PubMed ID: 12736647
    [No Abstract]   [Full Text] [Related]  

  • 54. [Antiretroviral therapy. A brief profile of all available drugs].
    Jablonowski H
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():18-29. PubMed ID: 10863306
    [No Abstract]   [Full Text] [Related]  

  • 55. Advances in HIV/AIDS care.
    Kurtyka D
    Nurs Spectr (Wash D C); 1997 Mar; 7(5):14. PubMed ID: 9433275
    [No Abstract]   [Full Text] [Related]  

  • 56. [New ammunition in the battle against AIDS].
    Agosto M
    Sidahora; 1997; ():25-6. PubMed ID: 11364803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. South African firm gets US approval for AIDS drugs.
    AIDS Read; 2005 Apr; 15(4):150. PubMed ID: 15846847
    [No Abstract]   [Full Text] [Related]  

  • 58. Group aims to silence claims that vitamins are better than drugs for AIDS.
    Sidley P
    BMJ; 2005 Jun; 330(7503):1288. PubMed ID: 15933350
    [No Abstract]   [Full Text] [Related]  

  • 59. HIV treatment: an overview.
    Moroni M
    J Biol Regul Homeost Agents; 2000; 14(1):32-3. PubMed ID: 10763889
    [No Abstract]   [Full Text] [Related]  

  • 60. Chemokine (C-C motif) receptor 5 entry inhibitors: new class of drugs for acquired immune deficiency syndrome.
    Jacovina A; New M
    Mt Sinai J Med; 2008; 75(3):297-8. PubMed ID: 18704982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.